PL3635096T3 - Sposób izolacji subpopulacji komórek progenitorowych serca i związane z nimi zastosowania w dziedzinie medycyny - Google Patents
Sposób izolacji subpopulacji komórek progenitorowych serca i związane z nimi zastosowania w dziedzinie medycynyInfo
- Publication number
- PL3635096T3 PL3635096T3 PL18735402T PL18735402T PL3635096T3 PL 3635096 T3 PL3635096 T3 PL 3635096T3 PL 18735402 T PL18735402 T PL 18735402T PL 18735402 T PL18735402 T PL 18735402T PL 3635096 T3 PL3635096 T3 PL 3635096T3
- Authority
- PL
- Poland
- Prior art keywords
- subpopulations
- isolation
- progenitor cells
- medical field
- cardiac progenitor
- Prior art date
Links
- 230000000747 cardiac effect Effects 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
- G01N2001/2873—Cutting or cleaving
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000062176A IT201700062176A1 (it) | 2017-06-07 | 2017-06-07 | Metodo per l’isolamento di sottopopolazioni di progenitori cellulari cardiaci e relativi usi in campo medico |
| EP18735402.2A EP3635096B1 (en) | 2017-06-07 | 2018-06-06 | Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field |
| PCT/IB2018/054057 WO2018224983A1 (en) | 2017-06-07 | 2018-06-06 | Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3635096T3 true PL3635096T3 (pl) | 2021-12-13 |
Family
ID=60138749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18735402T PL3635096T3 (pl) | 2017-06-07 | 2018-06-06 | Sposób izolacji subpopulacji komórek progenitorowych serca i związane z nimi zastosowania w dziedzinie medycyny |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12006514B2 (pl) |
| EP (1) | EP3635096B1 (pl) |
| JP (1) | JP7543630B2 (pl) |
| KR (1) | KR102490731B1 (pl) |
| CN (1) | CN110785485A (pl) |
| AU (1) | AU2018279290B2 (pl) |
| CA (1) | CA3061890A1 (pl) |
| DK (1) | DK3635096T3 (pl) |
| ES (1) | ES2887773T3 (pl) |
| IL (1) | IL270572B2 (pl) |
| IT (1) | IT201700062176A1 (pl) |
| PL (1) | PL3635096T3 (pl) |
| SI (1) | SI3635096T1 (pl) |
| WO (1) | WO2018224983A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210317412A1 (en) * | 2018-07-16 | 2021-10-14 | Agency For Science, Technology And Research | Method For Isolating A Cardiomyocyte Population |
| NL2024163B1 (en) * | 2019-11-05 | 2021-07-20 | Univ Of Salamanca | Means and methods for multiparameter cytometry-based leukocyte subsetting. |
| CN112147326B (zh) * | 2020-09-04 | 2022-04-08 | 北京大学 | 一种肿瘤免疫细胞亚群分型精准检测试剂盒 |
| CN112462065A (zh) * | 2020-11-16 | 2021-03-09 | 浙江博真生物科技有限公司 | 一种用于检测实体肿瘤的抗体组合物、试剂盒及检测方法 |
| CN118489005A (zh) * | 2021-10-27 | 2024-08-13 | 苏州博腾生物制药有限公司 | 用于开发用于在悬浮细胞培养中产生病毒的细胞系的方法 |
| CN114149964A (zh) * | 2021-12-29 | 2022-03-08 | 中国人民解放军陆军军医大学 | 一种从小鼠心脏分离提取纤维细胞的方法 |
| CN117448259A (zh) * | 2023-10-20 | 2024-01-26 | 苏州思萃免疫技术研究所有限公司 | 一种间质细胞的筛选方法及其在结肠癌类器官培养中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080075750A1 (en) * | 2001-05-11 | 2008-03-27 | The Nemours Foundation | Methods for producing three-dimensional tissue-engineered cardiac constructs and uses regarding same |
| JP2004290056A (ja) * | 2003-03-26 | 2004-10-21 | Sumitomo Chem Co Ltd | 心筋細胞の調製方法及びそれに利用する装置 |
| WO2011057249A2 (en) * | 2009-11-09 | 2011-05-12 | The Brigham And Women's Hospital, Inc. | Treatment of heart disease |
| WO2013184527A1 (en) * | 2012-06-05 | 2013-12-12 | Capricor, Inc. | Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy |
| EP2914273B1 (en) | 2012-10-26 | 2018-07-04 | Cedars-Sinai Medical Center | Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair of regeneration |
| EP2925863B1 (en) * | 2012-11-30 | 2020-07-15 | Vestion Inc. | Cardiac stem cells and methods of identifying and using the same |
| EP2792742A1 (en) | 2013-04-17 | 2014-10-22 | Universitätsklinikum Hamburg-Eppendorf (UKE) | Gene-therapy vectors for treating cardiomyopathy |
-
2017
- 2017-06-07 IT IT102017000062176A patent/IT201700062176A1/it unknown
-
2018
- 2018-06-06 US US16/617,429 patent/US12006514B2/en active Active
- 2018-06-06 EP EP18735402.2A patent/EP3635096B1/en active Active
- 2018-06-06 ES ES18735402T patent/ES2887773T3/es active Active
- 2018-06-06 WO PCT/IB2018/054057 patent/WO2018224983A1/en unknown
- 2018-06-06 PL PL18735402T patent/PL3635096T3/pl unknown
- 2018-06-06 CA CA3061890A patent/CA3061890A1/en active Pending
- 2018-06-06 JP JP2020518591A patent/JP7543630B2/ja active Active
- 2018-06-06 CN CN201880036451.7A patent/CN110785485A/zh active Pending
- 2018-06-06 KR KR1020197038194A patent/KR102490731B1/ko active IP Right Grant
- 2018-06-06 AU AU2018279290A patent/AU2018279290B2/en active Active
- 2018-06-06 DK DK18735402.2T patent/DK3635096T3/da active
- 2018-06-06 SI SI201830369T patent/SI3635096T1/sl unknown
-
2019
- 2019-11-11 IL IL270572A patent/IL270572B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7543630B2 (ja) | 2024-09-03 |
| KR20200015585A (ko) | 2020-02-12 |
| CA3061890A1 (en) | 2018-12-13 |
| KR102490731B1 (ko) | 2023-01-19 |
| IL270572A (pl) | 2019-12-31 |
| US20200140818A1 (en) | 2020-05-07 |
| IL270572B1 (en) | 2023-04-01 |
| CN110785485A (zh) | 2020-02-11 |
| US12006514B2 (en) | 2024-06-11 |
| JP2020522282A (ja) | 2020-07-30 |
| EP3635096A1 (en) | 2020-04-15 |
| SI3635096T1 (sl) | 2021-10-29 |
| WO2018224983A1 (en) | 2018-12-13 |
| AU2018279290B2 (en) | 2024-02-29 |
| ES2887773T3 (es) | 2021-12-27 |
| DK3635096T3 (da) | 2021-09-06 |
| IL270572B2 (en) | 2023-08-01 |
| IT201700062176A1 (it) | 2018-12-07 |
| EP3635096B1 (en) | 2021-07-28 |
| AU2018279290A1 (en) | 2019-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3635096T1 (sl) | Metoda za izolacijo subpopulacij srčnih matičnih celic in povezane uporabe na medicinskem področju | |
| EP3445307A4 (en) | IN VIVO DEVICE AND METHOD OF USE | |
| IL254734B1 (en) | Modified t cells and methods for their preparation and use | |
| EP3445221A4 (en) | IN VIVO DEVICE AND METHOD OF USE | |
| EP3528823A4 (en) | DETERMINIST LATERAL SHIFTING IN THE PRODUCTION OF CELLS AND COMPOSITIONS FOR THERAPEUTIC USE | |
| EP3601528A4 (en) | CELLS AND METHODS OF USE AND PRODUCTION OF THEM | |
| EP3402543A4 (en) | CELLS DERIVED FROM CARDIOSPHERES AND EXOSOMES SECRETED BY THESE CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION | |
| EP3328399A4 (en) | Modified cells and methods of therapy | |
| EP3253441A4 (en) | Medical apparatus including an implantable system and an external system | |
| EP3274713A4 (en) | Method and system for determining integrated metabolic baseline and potential of living cells | |
| EP3200808A4 (en) | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy | |
| EP3568467A4 (en) | MODIFIED T LYMPHOCYTES AND THEIR METHODS OF USE | |
| HUE065734T2 (hu) | Genetikailag módosított trehaláz-kiválasztó élesztõk és az ilyen genetikailag módosított élesztõket alkalmazó erjesztési eljárások | |
| GB201700621D0 (en) | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue | |
| EP3531918A4 (en) | DEVICES FOR USE IN MEDICAL IMAGING AND METHODS OF USING THEREOF | |
| EP3532605A4 (en) | ENHANCED GENERATION OF MUSCLE LINE CELLS AND THEIR THERAPEUTIC USES | |
| EP3378462A4 (en) | PORTABLE VEST FOR THE APPLICATION OF LUNG THERAPY AND ASSOCIATED PROCEDURE | |
| MY193650A (en) | Extracellular matrix compositions | |
| HK1245403B (zh) | 層叠體的剝離檢查方法和剝離檢查裝置 | |
| IL259095A (en) | A device for isolating cell segments from human and animal tissues and a method for using it | |
| IL282220B (en) | Genetically modified cells that are resistant to drugs and methods for their use | |
| EP3265134A4 (en) | METHOD FOR CELL MARKINGS AND MEDICAL IMAGING | |
| IL266609A (en) | Red blood cell targeted factor viii and method of using the same | |
| EP3752950A4 (en) | USE OF CRYPTOCURRENCY IN HEALTH CARE | |
| GB2528421A (en) | Methods and processes for application of drug delivery polymeric coatings |